Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 163
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00373360 | Safety, Efficacy and Treatment Satisfaction in Patients With PAH Rapidly Switched From Epoprostenol to Remodulin | ||
| NCT01273922 | Safety and Immunogenicity Study of a Recombinant Protein Vaccine (NDV-3) Against S.Aureus and Candida | ||
| NCT02318186 | Pharmacokinetic Study of Sub-q and IV Treprostinil in Kids With Pulmonary Arterial Hypertension (PAH) | ||
| NCT01566877 | A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7288 in Healthy Adult Volunteers | ||
| NCT04707664 | Sargramostim Use in COVID-19 to Recover Patient Health | ||
| NCT01165476 | Comparative Bioavailability of Treprostinil Diethanolamine Manufactured by Two Independent Facilities | ||
| NCT05245006 | PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate Cancer | ||
| NCT01996254 | Electrical Stimulation for the Treatment of Post-Amputation Pain Using the SPRINT System | ||
| NCT01494896 | Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching | ||
| NCT01321073 | DelIVery for Pulmonary Arterial Hypertension (PAH) & Continued Support Study | ||
| NCT01588405 | Remodulin® to Oral Treprostinil Transition | ||
| NCT05564637 | A Study of Treprostinil to Treat Interstitial Lung Disease Pulmonary Hypertension | ||
| NCT07116681 | Effects of Inhaled Treprostinil on Exercise Performance in Exercise Induced Pulmonary Hypertension | ||
| NCT00147199 | Clinical Investigation Into Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension (PAH) | ||
| NCT02893995 | Safety, Tolerability, Pharmacokinetics and Efficacy of Two Different Rates of Subcutanous Remodulin® Dose Titration in Pulmonary Arterial Hypertension | ||
| NCT02360345 | Phase I Trial of ONX-0801 Once Weekly or Alternate Weekly | ||
| NCT00848107 | Open-Label Study of Oral Treprostinil in Digital Ulcers | ||
| NCT00969722 | A Study of MAb-3F8 Plus Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus 13-cis-Retinoic Acid (RA) Plus GM-CSF in Primary Refractory Neuroblastoma Patients | ||
| NCT01353040 | Safety Study of Single Administration Post-exposure Prophylaxis Treatment for Marburg Virus | ||
| NCT01268553 | Transition From Injectable Prostacyclin Medication to Inhaled Prostacyclin Medication | ||
| NCT00508586 | PTC299 and Hormonal Agent for Treatment of Metastatic Breast Cancer | ||
| NCT04870333 | PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V | ||
| NCT04246281 | The RESET Clinical Trial: SPRINT® Peripheral Nerve Stimulation for the Treatment of Back Pain | ||
| NCT02999906 | Study to Compare Triple Therapy (Oral Treprostinil, Ambrisentan, and Tadalafil) With Dual Therapy (Ambrisentan, Tadalafil, and Placebo) in Subjects With Pulmonary Arterial Hypertension | ||
| NCT01477333 | Addition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Receiving Tyvaso® | ||
| NCT02261883 | Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn | ||
| NCT03016468 | Safety of Transition From Selexipag to Remodulin® Then Oral Treprostinil in Symptomatic Adult PAH | ||
| NCT05848687 | TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II | ||
| NCT06450041 | NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial | ||
| NCT00458042 | Transitioning To IV Remodulin From Ventavis in Patients With PAH: Safety, Efficacy and Treatment Satisfaction | ||
| NCT02847260 | Safety and Tolerability of Rapid Dose Titration of Subcutaneous Remodulin® Therapy in PAH Subjects (RAPID) | ||
| NCT01560624 | Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy | ||
| NCT03950739 | Open-label, Clinical Study to Evaluate the Safety and Tolerability of TreT in Subjects With PAH Currently Using Tyvaso | ||
| NCT01447407 | Effect of Adjuvant & Route of Administration on Safety & Immunogenicity of NDV-3 Vaccine | ||
| NCT01557647 | Safety and Efficacy of Inhaled Treprostinil in Patients With PAH | ||
| NCT03888365 | Patient Global Impression Questions for Activity-Induced Symptoms in Participants With PAH | ||
| NCT04050449 | Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance Following Initiation of TLD | ||
| NCT02583789 | Assess Efficacy of of Oral Treprostinil in Patients With Symptomatic Primary or Secondary Raynaud's Phenomenon | ||
| NCT07037836 | Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia | ||
| NCT01884038 | Safety and Efficacy of Perioperative Remodulin® in Orthotopic Liver Transplant Recipients | ||
| NCT06059118 | Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer | ||
| NCT00775463 | Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine | ||
| NCT05735249 | A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Oral ARN-75039 in Healthy Adult Subjects | ||
| NCT00069511 | 12 Week Study of Anti-Viral Effect of Oral UT-231B in Non-cirrhotic Hepatitis C Patients who have Failed Interferon-based Therapy. | ||
| NCT03332667 | MIBG With Dinutuximab +/- Vorinostat | ||
| NCT01795950 | Safety Study of PLX-PAD Cells to Treat Pulmonary Arterial Hypertension (PAH) | ||
| NCT04850105 | A Non-interventional Cohort Safety Study of Patients With hATTR-PN | ||
| NCT01043627 | Sildenafil to Tadalafil in Pulmonary Arterial Hypertension (SITAR) | ||
| NCT01934582 | A Pharmacokinetic Substudy of the TDE-PH-304 Protocol | ||
| NCT00705133 | Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial Hypertension |
